切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2011, Vol. 05 ›› Issue (03) : 195 -197. doi: 10.3877/cma.j.issn.1674-0793.2011.03.004

所属专题: 文献

论著

Livin mRNA在结直肠癌、腺瘤和正常黏膜中的表达差异及意义
王永1,(), 宋怡才1, 尹作文1, 喻军1, 刘军辉1, 李一帆2, 郭梅梅3   
  1. 1. 518052 深圳,广东医学院附属南山医院胃肠外科
    2. 518052 深圳,广东医学院附属南山医院中心实验室
    3. 518052 深圳,广东医学院附属南山医院消化内科
  • 收稿日期:2011-03-04 出版日期:2011-06-01
  • 通信作者: 王永
  • 基金资助:
    深圳市科技计划项目基金资助(201003280)

Expression difference of Livin mRNA in colorectal carcinoma, adenoma, and normal colorectal mucosa and its clinical significance

Yong WANG1,(), Yi-cai SONG1, Zuo-wen YIN1, Jun YU1, Jun-hui LIU1, Yi-fan LI2, Mei-mei GUO3   

  1. 1. Department of Gastrointestinal Surgery, Nanshan Hospital, GuangDong Medical College, ShenZhen 518052, China
  • Received:2011-03-04 Published:2011-06-01
  • Corresponding author: Yong WANG
  • About author:
    Corresponding auther: WANG Yong, Email:
引用本文:

王永, 宋怡才, 尹作文, 喻军, 刘军辉, 李一帆, 郭梅梅. Livin mRNA在结直肠癌、腺瘤和正常黏膜中的表达差异及意义[J/OL]. 中华普通外科学文献(电子版), 2011, 05(03): 195-197.

Yong WANG, Yi-cai SONG, Zuo-wen YIN, Jun YU, Jun-hui LIU, Yi-fan LI, Mei-mei GUO. Expression difference of Livin mRNA in colorectal carcinoma, adenoma, and normal colorectal mucosa and its clinical significance[J/OL]. Chinese Archives of General Surgery(Electronic Edition), 2011, 05(03): 195-197.

目的

探讨凋亡抑制蛋白Livin在结直肠癌、结直肠腺瘤及正常结直肠黏膜中的表达差异及意义。

方法

应用实时荧光定量法检测Livin mRNA在64例结直肠癌、36例结直肠腺瘤及12例正常黏膜中的表达,并用REST-XL?软件作基因表达的相对定量统计学分析。

结果

Livin mRNA的表达量在正常结肠黏膜组织、结直肠腺瘤组织及结直肠癌组织中依次增高,结直肠癌与结直肠腺瘤及正常结直肠黏膜相比较,Livin mRNA的表达上调且差异有统计学意义(P=0.001)。与正常黏膜相比,结直肠腺瘤中Livin mRNA表达上调,但差异无统计学意义(P=0.19)。

结论

凋亡抑制蛋白Livin参与了大肠肿瘤的发生,且在大肠腺瘤-腺癌阶段起到了重要作用。

Objective

To compared the difference of Livin mRNA expression among colorectal adenocarcinoma, colorectal adenoma and normal mucosa, to further investigate the potential role of Livin in carcinogenesis.

Methods

The expressions of Livin mRNA were determined by real-time RT-PCR in tissues of 12 colorectal normal mucosa, 36 colorectal adenomas and 64 colorectal carcinomas. Date were evaluated by relative expression software tool (REST-XL?).

Results

The expression of Livin mRNA elevated in turn by colorectal normal mucosa, adenoma and adenocarcinoma. The expression of Livin mRNA in colorectal carcinomas was significantly higher than that in adenomas, as well as significantly higher than that in normal mucosa (P= 0.001), while the diffence between adenoma and normal mucosa was not significant (P=0.19).

Conclusions

The difference in expression of Livin between adenoma and adenocarcinoma indicates that Livin might play an important role in carcinogenesis of colorectal cancer.

表1 Livin mRNA在正常结直肠黏膜、腺瘤及结直肠癌组织中的表达差异
1
Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin, 2007, 57: 43-66.
2
陈创奇,马晋平,卢砺锋,等. 综合措施提高结直肠癌术后患者的随访率[J/CD]. 中华普通外科学文献:电子版, 2010, 4(6): 579-582.
3
Huerta S, Goulet EJ, Livingston EH. Colon cancer and apoptosis. Am J Surg, 2006, 191: 517-526.
4
Rupnarain C, Dlamini Z, Naicker S, et al. Colon Cancer: genomics and apoptotic events. Biol Chem, 2004, 385(6): 449-464.
5
Watson AJ. An overview of apoptosis and the prevention of colorectal cancer. Crit Rev Oncol Hematol, 2006, 57(2): 107-121.
6
Lin JH, Deng G, Huang Q, et al. KIAP, a novel member of the inhibitor of apoptosis protein family. Biochem Biophys Res Commun, 2000, 279(3): 820-831.
7
Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res, 2002, 30: e36.
8
Kawasaki H, Toyoda M, Shinohara H,, et al. Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis. Cancer, 2001, 91(11): 2026-2032.
9
Tannapfel A, Neid M, Aust D, et al. The origins of colorectal carcinoma: specific nomenclature for different pathways and precursor lesions.. Dtsch Arztebl Int, 2010, 107(43): 760-766.
10
Liu B, Han M, Wen JK, et al. Livin/ML-IAP as a new target for cancer treatment. Cancer Letter, 2007, 250(2): 168-176.
11
Choi J, Hwang YK, Sung KW, et al. Expression of Livin, an antiapoptotic protein, is an independent favorable prognostic factor in childhood acute lymphoblastic leukemia. Blood, 2007, 109(2): 471-477.
12
郭冬梅, 王淑秋, 崔新刚. Livin基因在结直肠癌的表达及其与PTEN、β-Catenin的相关性研究. 牡丹江医学院学报, 2009, 30(2): 9-11.
13
Vucic D, Stennicke HR, Pisabarro MT, et al. ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas. Curr Biol, 2000, 10(21): 1359-1366.
[1] 罗青杉, 梅海涛, 郝家领, 蔡锦锋, 周润楷, 温玉刚. 连接蛋白43通过调控细胞周期抑制结直肠癌的增殖机制研究[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 344-349.
[2] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[3] 谢丽春, 欧庆芬, 张秋萍, 叶升. 简化和标准肝脏MRI方案在结直肠癌肝转移患者随访中的临床应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 434-437.
[4] 施烨鑫, 马翔, 鲁明, 夏青城, 王鹏超, 宋青雨, 赵庆洪. 腹腔镜下结直肠肿瘤定位研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 463-466.
[5] 韩加刚, 王振军. 梗阻性左半结肠癌的治疗策略[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 450-458.
[6] 梁轩豪, 李小荣, 李亮, 林昌伟. 肠梗阻支架置入术联合新辅助化疗治疗结直肠癌急性肠梗阻的疗效及其预后的Meta 分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 472-482.
[7] 严虹霞, 王晓娟, 张毅勋. 2 型糖尿病对结直肠癌患者肿瘤标记物、临床病理及预后的影响[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 483-487.
[8] 赵磊, 刘文志, 林峰, 于剑, 孙铭骏, 崔佑刚, 张旭, 衣宇鹏, 于宝胜, 冯宁. 深部热疗在改善结直肠癌术后辅助化疗副反应及生活质量中的作用研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 488-493.
[9] 黄海洋, 邝永龙, 陈嘉胜. 基层医院结直肠肿瘤经自然腔道取标本手术30 例分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 510-518.
[10] 张蔚林, 王哲学, 白峻阁, 黄忠诚, 肖志刚. 利用TCGA数据库构建基于miRNA的结直肠癌列线图预后模型[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 381-388.
[11] 张伟伟, 陈启, 翁和语, 黄亮. 随机森林模型预测T1 期结直肠癌淋巴结转移的初步研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 389-393.
[12] 任佳琪, 刁德昌, 何自衍, 张雪阳, 唐新, 李文娟, 李洪明, 卢新泉, 易小江. 网膜融合线导向的脾曲游离技术在左半结肠癌根治术中的应用[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 362-367.
[13] 张迪, 王春霞, 张学东, 李发馨, 庞淅文, 陈一锋, 张维胜, 王涛. 梗阻性左半结直肠癌自膨式金属支架置入后行腹腔镜手术与开腹手术的短期临床疗效比较[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 375-380.
[14] 季鹏程, 鄂一民, 陆晨, 喻春钊. 循环外泌体相关生物标志物在结直肠癌诊断中的研究进展[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(04): 265-273.
[15] 李佳莹, 王旭丹, 梁雪, 张雷, 李佳英. 1990~2021年中国结直肠癌死亡趋势分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(04): 274-279.
阅读次数
全文


摘要